Up to 3.4 million eligible patients could benefit from the medication that treats type 2 diabetes and aids weight loss ...

Novo Nordisk, the maker of Ozempic, has questioned the reported results, saying the optimal dosage for weight loss for its drug was not released. However, Mounjaro is getting a following ...

NVO), has already been available on the NHS since late 2023 for people who meet the criteria Mounjaro, which is injected weekly, will cost the NHS £122 per patient per month for the maximum dose with ...